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IN 1968, Boyland, Carter, Gorrod and Roe investigated the possible carcino-
genicity of four additives used in the rubber industry. The compounds were
administered by repeated intraperitoneal injection in stock CB Wistar rats and
two of them polymerised N-nitroso-2,2,4-trimethyl-1,2-dihydroquinoline and
N-methyl-N,4-dinitrosoaniline-were shown to induce local (intra-abdominal)
sarcomata. The polymerised nitroso compound was the more potent of the two
carcinogens and it was decided to study this substance in more detail. Three
different routes of administration subcutaneous injection, intraperitoneal
injection and force feeding have now been examined and the results are presented
here. The moderate carcinogenic activity of this material in the rat has been
confirmed but the new findings are of wider interest as they throw some light on
the early development of induced sarcomata in this species.
MATERIALS AND METHODS
Experimental anirnals.-Two hundred Sprague-Dawley rats, 100 males and 100
females, were used. The animals, which were 7 to 8 weeks old at the beginning
of the experiment, were Caesarean section-derived and maintained under barrier
conditions in a minimal disease unit; bedding and food were sterilised before use.
They were housed in metal cages, five animals in each, and fed Spiller's autoclaved
diet and water ad libitum.
Rubber additive. The rubber additive (polymerised N-nitroso-2,2,4-trimethyl-
1,2-dihydroquinoline, " Curetard ": Monsanto Ltd.) was kindly supplied by
Professor Boyland; in the interests of brevity it is subsequently referred to as
NTDQ. It was stored at room temperature and was suspended in polyethylene
glycol (PEG: British Drug Houses Ltd.) before use.
Conduct of experiment.-The rats were divided into five groups, each com-
prising 20 males and 20 females. Animals in Group 1 received 20 once weekly
subcutaneous injections of 25 mg. NTDQ/0*25 ml. polyethylene glycol in the flanks
(ten injections on the right side followed by ten injections on the left). Rats in
Group 2 received the same dose of NTDQ administered by once weekly intra-
peritoneal injection. Rats in Group 3 were force-fed 25 mg. NTDQ/0.25 ml.
polyethylene glycol thrice weekly for 20 weeks. Animals in Group 4 received 20
weekly injections of 0*25 ml. polyethylene glycol only in the right and left flanks,
as in Group 1, and Group 5 consisted of untreated control rats. (Unfortunately,
insufficient Sprague-Dawley rats were available to include a vehicle control for
the group injected intraperitoneally, but some information on the effect of intra-RAT SARCOMAS INDUCED BY RUBBER ADDITIVE
TABLE I.-Experimental Details
No. of
Group rats
I /S? 20
\c3 20
2 /9 20 \d 20
3 /y ?20
* \ 20
4 /y 20
\,c 20
5 /$? 20
* \d 20
Treatment
25 mg. NTDQ/0*25 ml. polyethylene glycol; subcutane-.
ously into alternate flanks*; x 1/week for 20 weeks.
25 mg. NTDQ/0-25 ml. polyethylene glycol; intra-
peritoneal; x 1/week for 20 weeks.
25 mg. NTDQ/0 25 ml. polyethylene glycol; oral;
x 3/week for 20 weeks.
0* 025 ml. polyethylene glycol; subcutaneous; x 1/week
for 20 weeks.
Untreated controls.
* Ten once-weekly injections successively into the right flank, followed by ten
injections into the left side.
Total amount
of NTDQ
administered
500 mg.
500 mg.
1500 mg.
None
None
similarly spaced
peritoneal polyethylene glycol was available from the previous report by Boyland
et al., 1968.) Details of treatment in the five groups are summarised in Table I.
The rats were examined regularly until the termination ofthe experiment after
106 weeks. They were killed with CO2 and full post-mortem examinations were
made. All injection sites and other tissues showing macroscopic abnormalities
were fixed in Bouin's solution. Paraffin sections were prepared at 5,t and stained
with haematoxylin and eosin and, in selected tissues, with Orcein and Van Gieson,
Masson's trichrome, Gordon and Sweets' silver impregnation technique, periodic
acid-Schiff (PAS), toluidine blue, and alcian blue and chlorantine fast red.
RESULTS
Overall survival ofrats in the test and control groups was excellent (Table II).
The decreased survival among females after 90 weeks was due to the high incidence
ofspontaneous mammary tumours which is a characteristic feature ofthe Sprague-
Dawley strain. Most of these tumours were benign (Table IV) but they grew
rapidly and it was necessary to kill several animals in the last few weeks of the
experiment.
TABLE II.-Survival in Test and Control Groups
Survivors at:
A
GROUP 1
Subcutaneous NTDQ
GROUP 2
Intraperitoneal NTDQ
GROUP 3
Oral NTDQ
GROUP 4
Subcutaneous polyethylene glycol
GROUP 5
Untreated controls
M
F
M
F
M
F
M
F
M
F
70 weeks
20
20
20
20
20
20
20
20
20
20
80 weeks 90 weeks
20
20
14
20
20
20
19
20
20
19
19
15
17
18
19
19
19
17
16
18
Note: The decreased survival in female rats was due to their high incidence of mammary tumours
(common to Sprague-Dawley rats), which developed between the 90th and 100th weeks.
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100 weeks
14
4
15
10
13
15
17
9
13
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Neoplastic changes at the site of injection were observed in two groups (Table
III): in rats injected with NTDQ subcutaneously (Group 1) and intraperitoneally
(Group 2). No local tumours were produced in animals force-fed with NTDQ
(Group 3) nor in rats injected subcutaneously with polyethylene glycol alone
(Group 4). One spontaneous sarcoma was observed in an untreated control
animal from Group 5. It is obvious from Table III that a large proportion ofthe
sarcomata found in rats from Groups 1 and 2 were unsuspected during life and
were first recognised at autopsy or in the course of histological examination.
TABLE III.-Development of Sarcomas, Early Sarcornas and Fibromas in Sub-
cutaneous Tissues and in the Peritoneal Cavity ofRatsfrom Test and Control Groups
Sarcomas
Sarcomas
Sarcomas first Sarcomas first
No. of diagnosed diagnosed diagnosed by
Experimental group rats during life at autopsy microscopy Fibromas
GROUP I. 20 4 2 14 . 0
Subcutaneous (81, 96, 104, (96, 99) (96, 96, 96, 96, 99, 104,
NTDQ 106) 104, 104, 104, 105, 105,
105, 106, 106)
V . 20. 1 2 6
(96) (96, 96) (96, 96, 96, 106, 106,
106)
GRouP 2 d. 20 1* 0 2 0
Intraperitoneal (104, 105)
NTDQ ° . 20. 0 0 1 . 0
(99)
GROUP 3 3. 20 . 0 0 0 . 1t
Oral NTDQ S . 20 . 0 0 0 .
GROUP 4 ,. 20. 0 0 0 . 0
Subcutaneous V . 20 . 0 0 0 0
polyethylene
glycol
GROUP5 C. 20 . 1§ 0 0 . 0
Untreated ? . 20 . 0 0 0 . 0
controls
Note8: Numbers in parentheses refer to stage of experiment (weeks) when lesions were observed.
* Tumour developed on left flank, opposite to the one through which intraperitoneal injections
were made.
t Tumour developed on left foreleg.
t Tumour developed on right scapular region.
§ Tumour developed on chest wall.
All tumours marked t, t, $, or § are also listed in Table IV.
(A) Local Changes Induced by NTDQ
Group 1: NTDQ injected subcutaneously
After about 8 once weekly injections ofNTDQ, the subcutaneous tissues in the
flanks became increasingly thickened and indurated. Discrete nodules were
palpable after approximately 8 months and these slowly increased in size. No
epidermal ulceration developed at any time and the growth of hair over the
injected flanks was unaltered.
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The gross appearance of an excised injection site is illustrated in Fig. 1:
circumscribed nodular masses are seen in the subcutaneous tissues, infiltrating
downwards between the layers of the body wall. Local tumours stood out as
paler regions but it is not surprising that four of the nine sarcomata which were
recognised macroscopically in this group (Table III) were not suspected while the
animal was alive. These four neoplasms were all small, slowly-growing lesions,
0.5 to 1-5 cm. in diameter, which were indistinguishable (during life) from other
innocent nodules palpable in the injected flank.
Histological chunges.-Three main histological pictures were encountered
which, when all the material was reviewed, appeared to develop sequentially.
I. The predominant lesion, present in all rats from this group, was composed
of masses of multinucleate giant cells and fibroblasts. The giant cells measured
up to 60,u in diameter and contained 30 to 50 vesicular nuclei arranged round most
or all of the cell perimeter (Fig. 2 and 3). Their cytoplasm was eosinophilic,
vacuolated and, in some cells, contained fine darkly-stained granules which
appeared to be engulfed injection material. Many cells stained deeply with PAS
and, to a lesser extent, with alcian blue. Smaller cells in mitosis were occasionally
seen. Fibroblasts and collagen fibres extended between the masses of multi-
nucleate cells and there was a dense reticulin framework. There were no
inflammatory cells or zones of necrosis.
II. Twenty ofthe 40 rats-14 males and 6 females-showed additional micro-
scopic changes which were regarded as compatible with early sarcoma.
The first alteration in the pre-existing lesions was a patchy increase in fibro-
blastic elements which tended to break up the solid masses of surrounding multi-
nucleate giant cells (Fig. 4). Somewhat myxomatous ground substance was
also increased in these regions; it stained positively with alcian blue, meta-
chromatically with toluidine blue but was PAS-negative. At a higher magnifica-
tion (Fig. 5), the fibroblasts were seen to be atypical in structure and mitotic
figures were common. Such foci of abnormal proliferation were initially very
smail, irregularly distributed and difficult to evaluate. But they appeared to
increase in size and gradually become organised into discrete nodules, sharply
demarcated from the surrounding multinucleate giant cells (Fig. 6). At this
stage, the morphological abnormalities oftheir component fibroblasts were beyond
doubt (Fig. 7). Collagen fibres in these nodules were thin, sparse and often
fragmented; some of them were stained strongly by PAS. Reticulin fibres were
also reduced in number and showed fragmentation and a predominance of fine
fibrils.
III. Overt sarcomata were observed in nine animals, six males and three
females. Five of the tumours were large and had extensively invaded the under-
lying injection site. The remaining four sarcomata were too small to be identi-
fied during life. No metastases were seen. Section of injection sites bearing
these small lesions contained foci of neoplastic cells which differed from those
previously described (for example, Fig. 6) in that they now formed irregularly
outlined masses which were invading and destroying the surrounding multi-
nucleate giant cells (Fig. 8).
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Irrespective of their size, the nine injection site sarcomata were all similar in
structure and consisted of well-differentiated spindle cell lesions (Fig. 9) with
moderate amounts of collagen.
No fibromas were observed at any of the injection sites.
Group 2: NTDQ injected intraperitoneally
Extensive macroscopic changes were seen at autopsy. The abdominal cavity
contained fibrous adhesions and small amounts of ascitic fluid, sometimes blood-
stained. Numerous yellow deposits in the form of nodules or plaques, measuring
up to 5 mm. in diameter, were seen in the following sites: between the upper
surface of the liver and the right cupula of the diaphragm; in connective tissues
surrounding the stomach, spleen and pancreas; in the omentum and mesentery;
in perirenal fat; and around the uterine horns, bladder and vagina. There was
occasionally evidence of extension into the body wall, probably due to leakage of
NTDQ along the injection track.
Histological change&.-In most rats, the plaques or nodules in the abdominal
cavity were composed of dense masses of multinucleate giant cells and fibroblasts
similar to those described in the subcutaneous tissues (Fig. 10). Parenchymal
structures such as the liver and pancreas were sometimes compressed by such
deposits but there was no evidence of deep infiltration.
In three rats, nodules were found which showed early neoplastic changes: an
example, from a nodule in the omentum, is shown in Fig. 11. This animal was of
particular interest as the lesion in the mesentery was accompanied by a similar
nodule in the parenchyma of the right lung (Fig. 12). No foci of overt sarcoma
were found in either sites after examining a large number of serial sections. The
pulmonary lesion is indistinguishable from those described in the subcutaneous
tissues and in the abdominal cavity (compare Fig. 12, 11 and 6); it resembles no
known primary pulmonary lesion and it was finally concluded that it was a
EXPLANATION OF PLATES
FIG. 1.-Injection site from rat in Group 1; 104 weeks. Gross specimen showing circum-
scribed nodules in the subcutaneous tissues, infiltrating the body wall. No visible sarcomas.
FIG. 2 and 3. Injection sites from rats in Group 1, killed at 90 and 100 weeks. Both contain
dense masses of multinucleate giant cells and fibroblasts. H. and E. x 215.
FIG. 4.-Injection site from rat in Group 1; 100 weeks. There is a focal increase in fibroblastic
elements and in ground substance, separating the masses of giant cells. H. and E. x 215.
FIG. 5. Injection site from rat in Group 1; 100 weeks. A tiny focus of abnormal fibroblasts.
H. and E. x 380.
FIG. 6. Injection site from rat in Group 1; 96 weeks. An early sarcoma which is still
sharply demarcated from the surrounding giant cells. H. and E. x 130.
FIG. 7.-Injection site from rat in Group 1; 96 weeks. Higher power view ofan early sarcoma-
tous nodule. H. and E. x 205.
FIG. 8. Injection site from rat in Group 1; 102 weeks. Small focus of sarcoma which is
beginning to invade, engulfing the surrounding multinucleate giant cells. H. and E. x 205.
FIG. 9.-Injection site from rat in Group 1; 99 weeks. Local spindle-cell sarcoma. H. and E.
x 205.
FIG. 10. Rat from Group 2; 90 weeks. Plaque composed mainly of multinucleate giant cells
between upper surface of liver and diaphragm. H. and E. x 205.
FIG. 11.-Rat from Group 2; 104 weeks. Nodule from mesentery, similar in appearance to
early sarcomatous nodules in subcutaneous tissues (compare with Fig. 6). H. andE. x 205.
FIG. 12. Same rat as in Fig. 11. Early sarcomatous nodule in parenchyma oflung. H. and
E. x205.
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metastatic deposit. Sections from the mesentery and lungs were carefully
searched for evidence of tumour cell emboli in blood vessels, but none was seen.
No macroscopic sarcomas were induced in rats treated intraperitoneally with
NTDQ and no fibromas were seen.
Group 3: NTDQ administered orally
Despite the three-fold increase in dose of NTDQ, no local tumours were
produced in the gastrointestinal tract, the presumptive site of absorption of this
material. Similarly, no neoplasms were seen in the liver, kidneys or bladder
where absorbed NTDQ is presumably metabolised and excreted. One male and
one female from this group developed subcutaneous fibromas-the only animals
in the entire experiment in which this type ofneoplasm was found.
Group 4: Polyethylene glycol administered subcutaneously
The subcutaneous tissues from rats injected with polyethylene glycol showed
no microscopic abnormality.
(B) Distant Tumours in Treated and Control Rats
The incidence and distribution ofdistant neoplasms in rats from Groups 1 to 5
are shown in Table IV. A high incidence ofbreast tumours was noted in female
TABLE IV.-Incidence and Distribution ofTumours at Distant Sites
Group 1 Group 2 Group 3 Group 4 Group 5
Males
Adenocarci- . Squamous . Subcutaneous* . Phaeochromo- . Spindle cell
noma of carcinoma of fibroma. cytoma of sarcoma* of
L. kidney lower jaw. Subcutaneous left adrenal. chest wall and
Spindle cell haemangio- Subcutaneous§ fl-cell adenoma
sarcoma* of sarcoma. haemangio- of pancreas (in
flank. sarcoma. same rat).
Females
Mammary . Mammary fibro- . Mammary fibro- . Mammary fibro- . Mammary fibro-
fibro- adenoma (5). adenoma (8). adenoma (10). adenoma (4).
adenoma (10). Mammary Mammary Mammary Mammary
Mammary carcinoma (1). carcinoma (1). carcinoma (1). carcinoma (2).
carcinoma Subcutaneous* Basi-squamous
(2). Adeno- fibroma. carcinoma of
carcinoma of upper lip.
pancreas.
* These tumours are also listed in Table IIT. § Not at injection site.
rats in test and control groups and there was no evidence that treatment with
NTDQ increased the number of such tumours or shortened their latent period of
induction. No bladder tumours developed in any rats. Of the other neoplasms
encountered, the phaeochromocytoma observed in a control rat from Group 4 is
something of a rarity.
DISCUSSION
The present findings are discussed under two headings: the carcinogenicity of
NTDQ, and the early stages in the development of sarcomata induced in rats by
this material.
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The first topic has been considered elsewhere (Carter and Roe, 1969) and can
be dismissed briefly. It has been confirmed that NTDQ is carcinogenic in
Sprague-Dawley, as well as in Wistar rats, and it appears that the subcutaneous
tissues are more susceptible than the peritoneal cavity to such effects. On the
other hand, large doses of NTTDQ administered orally did not produce tumours of
the gastro-intestinal tract, liver, kidneys or bladder. If microscopic sarcomata
are temporarily discounted, it is clear that NTDQ is a weak carcinogen-even
though it contains a nitroso moiety in its molecule. The yield of local tumours
was small, their induction period was prolonged, and they were well-differentiated
lesions which did not metastasise. Furthermore, the number and distribution of
other neoplasms at distant sites were not increased. It is unlikely that the use of
minimal disease rats affected the outcome of the experiment. Rodents main-
tained under more rigorous germ-free conditions appear to be as sensitive to chemi-
cal carcinogens as normal rats and mice (Pollard, Matsuzawa and Salomon, 1964;
Pollard and Kajima, 1967).
The histological findings are of wider interest though caution is necessary in
the interpretation of a reconstructed series of histopathological events. The
accumulation of large numbers of multinucleate giant cells is reminiscent of the
early changes evoked by certain other injected carcinogens such as iron-dextran
(Baker, Golberg, Martin and Smith, 1961; Roe and Carter, 1967) although the
cells found in the present experiment have a most atypical morphology. These
collections of cells probably represent granulomas rather than " histiocytomas "
(Richmond, 1959; Haddow and Horning, 1960) and, although they may alter the
local physicochemical milieu sufficiently to favour neoplastic proliferation, it is
unlikely that sarcomata develop directly from these cells. The earliest malignant
changes are seen in connective tissues which extend between the giant cells,
occurring first in tiny irregular patches and then within well-defined microscopic
nodules. In some cases, the nodules eventually invade the surrounding tissues
and form overt neoplasms. The earliest of these changes has been described in a
number of circumstances but the later stages have not, possibly because the
carcinogens used by other investigators have all been a good deal more potent than
NTDQ. In the 1930's, foci of " abnormal fibroblasts ", " atypical spindle cells '
or " abnormal granulation tissue" were recorded in rats and mice bearing sub-
cutaneous implants of 3,4-benzopyrene, 3-methyleholanthrene or 7,12-dimethyl-
benz(a)anthracene (Rondoni, 1937; Orr, 1939; Stewart, 1939), and this earlier
work was later confirmed and extended by Vasilief and his colleagues (Vasilief,
1959; Vasilief et al., 1962). More recently, similar changes have been observed in
association with iron-dextran (Baker et al., 1961; Roe and Carter, 1967; Carter,
1969), and with various implanted plastics (Oppenheimer et al., 1958, 1964; Roe,
Dukes and Mitchley, 1967).
The morphology of the abnormal fibroblasts is described in similar terms in
the various accounts and there seems no doubt that, according to morphological
criteria, such cells are neoplastic. The abnormal fibroblasts were PAS-positive
in the present experiment, a feature which has also been observed by Vasilief
(Vasilief, 1959; Vasilief et al., 1962) who regarded it as an index of " dedifferentia-
tion " and " activation ". Changes in the ground substance have received less
attention. They were briefly noted in association with implants of carcinogenic
hydrocarbons by Orr (1939) and, in more detail, by Vasilief (1959) and Vasilief et
al. (1962). Using sodium sulphate containing 35S, Danishefsky et al. (1959)
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showed a striking increase in the synthesis of sulphated mucopolysaccharides in
the subcutaneous tissues of rats implanted with plastic films; autoradiographic
studies (Oppenheimer et al., 1960) later indicated that the cells involved were
confined to the connective tissue pocket surrounding the film. Increased amounlts
of metachromatic ground substance accompany fibroblastic proliferation in a
number of circumstances (Taylor and Saunders, 1957) and this change is not an
index of impending or actual malignant change.
One of the most striking features of the malignant changes induced by NTDQ
is the way in which tiny irregular foci ofabnormal fibroblasts and ground substance
are organised into the discrete, well-circumscribed nodules which have been
referred to as " early sarcomata ". Although there is convincing evidence that
some of these nodules later invade the surrounding tissues, it is not established
(a) whether the formation of early sarcomatous nodules is an essential inter-
mediate stage before invasive lesions develop, or (b) how many of these early
nodules become invasive. It is almost certain that not all foci of (presumptive)
neoplastic cells develop into overt sarcomata, a view which is supported by the
transplantation experiments of Stewart (1939) and by more recent observations
by Oppenheimer et al. (1964). These workers showed that cellophane implanted
into rats induced abnormal fibroblastic proliferation much earlier than implants
ofother plastics (4-5 weeks instead of5-6 months); despite this premature activity,
overt sarcomata induced by cellophane films did not appear significantly earlier
and the eventual yield of macroscopic tumours was no greater.
One comment may be made on the relevance of these observations to the
interpretation of carcinogenicity tests in the rat. If early sarcomatous changes
are found, should they be included in any final assessment ofcarcinogenic potency?
In the present circumstances, to do so would mean upgrading NTDQ from a weak
carcinogen to a rather potent one. The need for realistic criteria in evaluating
carcinogenicity tests in the rat has been cogently argued by Grasso and Golberg
(1966); until much more is known of the incidence, distribution, natural history
and significance of the early sarcomatous nodule, a proposal of this kind would be
undoubtedly premature.
SUMMARY
A rubber additive polymerised N-nitroso-2,2,4-trimethyl- 1,2-dihydroquino-
line (NTDQ) was administered for 20 weeks by the subcutaneous, intra-
peritoneal and oral routes to 120 young Sprague-Dawley rats. Local sarco-
matous changes were induced in rats injected subcutaneously and (to a lesser
extent) intraperitoneally; feeding of large doses of NTDQ was ineffective.
Some of the sarcomas which developed at injection sites were small lesions,
only recognised at autopsy; in many animals, sarcomatous changes were not
apparent until histological examination. These early sarcomatous lesions were
studied in detail and three stages of development have been tentatively defined.
(1) Tiny foci of abnormal fibroblasts, associated with increased amounts of
acid mucopolysaccharide ground substance, form between the pre-existing
masses of multinucleate giant cells which are seen at sites of injection of NTDQ.
(2) These foci of abnormal fibroblasts enlarge and form circumscribed nodules,
sharply demarcated from the surrounding tissues.
(3) Some of these nodules become irregular in outline, invade adjacent tissues,
and are recognisable as macroscopic neoplasms.
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Some of the changes evoked by NTDQ are reminiscent of the early neoplastic
reactions associated with more powerful carcinogens such as the polycyclic
hydrocarbons, macromolecular iron complexes, and certain plastics. The advan-
tages ofusing a weak carcinogen such as NTDQ to trace the early development of
induced sarcomata are discussed and some general implications of the present
findings with regard to the interpretation ofcarcinogenicity testing are considered.
I am indebted to Dr. F. J. C. Roe for help with the preparation ofthis account;
to Dr. Cuthbert Dukes for discussion of the histology; to Mrs. Joan Clack, Miss
Diana Bishop and Mr. E. Woollard for technical assistance; and to Mr. K. G.
Moreman and the staff ofthe Photographic Department, Chester Beatty Research
Institute, for the photomicrographs.
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